Stay updated on BOS-580 in NASH Obese Subjects Clinical Trial

Sign up to get notified when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BOS-580 in NASH Obese Subjects Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added: a new Lancet article citation for Efimosfermin BOS-580 (2026). Deleted: older related topics entry and an earlier Lancet preprint citation.
    Difference
    0.2%
    Check dated 2026-03-18T17:52:25.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision on the page updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T15:18:41.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics. These enhancements improve discoverability and provide additional context without altering study data or core content.
    Difference
    0.1%
    Check dated 2026-02-18T07:51:53.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added a Lancet publication citation for Efimosfermin (BOS-580) in Publications and updated the page revision to v3.4.2. Removed the funding lapse notice and related topics such as Non-alcoholic fatty liver disease and MedlinePlus Genetics.
    Difference
    0.4%
    Check dated 2026-02-11T09:17:32.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    Site-wide notices about a lapse in government funding and a version update to v3.4.1 are shown; the previous version v3.4.0 is removed. No changes to the study details, eligibility, or primary trial data are evident.
    Difference
    0.3%
    Check dated 2026-02-04T05:14:24.000Z thumbnail image
  8. Check
    50 days ago
    Change Detected
    Summary
    The page now shows a glossary and includes added terms such as Non-alcoholic fatty liver disease and MedlinePlus Genetics. It also updates revision metadata to v3.4.0 and removes older labels (e.g., No FEAR Act data and the prior revision label).
    Difference
    0.3%
    Check dated 2026-01-28T03:15:09.000Z thumbnail image

Stay in the know with updates to BOS-580 in NASH Obese Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.